Rapport Therapeutics Inc
Rapport Therapeutics Inc (RAPP) Option Chain
As of September 22, 2026, Rapport Therapeutics Inc is trading at $41.47, a +4.57% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 122.8%. IV Rank is 95%.
Read more
Tracking the RAPP option chain helps you see every strike and expiry on Rapport Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Rapport Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of RAPP options activity at a glance. Use our scanner to monitor the RAPP option chain in real time and filter for the RAPP options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For RAPP stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the RAPP option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where RAPP stock options are being actively traded and where they are not.
Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders.
The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is based in Boston, Massachusetts.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Rapport Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen RAPP options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of RAPP stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile98.81% Elevated
- Market cap (M$)1,990
- 52 weeks high-21.65%
- 52 weeks low74.61%
- Analyst recommendationStrong Buy
1.00 - Target price$63.09
52.13% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E—
- EPS (ttm)-3.04
- EPS growth next 5 years-24.34%
As of September 22, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 50.09 | 0 | 0 | 3.08 | 3.97 | 5.20 | 8.90 | 37.50 | -5.45 | 2.00 | 6.00 | 0.00 | 4.00 | 0 | 1 | 49.91 |
| 57.51 | 0 | 0 | 4.03 | 1.47 | 3.50 | 7.50 | 40.00 | +0.86 | 3.30 | 7.50 | 0.00 | 5.40 | 0 | 1 | 42.49 |
| 64.25 | 1 | 0 | 4.40 | 0.00 | 2.40 | 6.40 | 42.50 | +7.16 | 5.00 | 8.70 | 1.03 | 5.82 | 0 | 3 | 35.75 |
| 70.22 | 1 | 0 | 3.95 | 0.00 | 1.90 | 6.00 | 45.00 | +13.46 | 6.50 | 10.20 | 3.53 | 4.82 | 0 | 11 | 29.78 |
| 75.41 | 1 | 0 | 3.25 | 0.00 | 1.00 | 5.50 | 47.50 | +19.77 | 8.50 | 12.30 | 6.03 | 4.37 | 0 | 1 | 24.59 |
As of September 22, 2026
Scan the full option chain in one place
Browse the full RAPP option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→